People with pulmonary alveolus can take quick-acting heart-saving pills under the guidance of a doctor if they have coronary heart disease or angina pectoris. Quick-acting heart-saving pills have the efficacy of promoting qi circulation, activating blood circulation to remove blood stasis and relieving pain, and can clinically increase the blood flow in the coronary arteries, thus relieving angina pectoris. People with coronary heart disease and angina pectoris caused by qi stagnation and blood stasis (stagnation of blood due to lack of qi flow) can take the medicine for treatment. Pregnant women and people with allergies are not allowed to take SXP. People with allergies and a history of allergies should be cautious in using SXP. Individuals with chest pain (chest tightness and pain) caused by cold and blood stasis, as well as yin deficiency and blood stasis, are not suitable to use SXP alone. The adverse effects of SXRW are not known. People with pulmonary alveolus who suffer from the above symptoms may take SXRW under the guidance of a professional Chinese medicine practitioner. However, SXRL does not have the efficacy of treating alveoli, and people with alveoli need to strictly follow the doctor’s instructions when taking the medicine.